i2o Therapeutics
Boston-based biotech startup developing novel biologic therapies
Boston-based biotech startup developing novel biologic therapies
is a Boston-based biotech startup that is dedicated to developing next generation biologic therapies. The company, founded in 2019, operates in the industries of biotechnology, health care, and health and wellness. Recently, on 28 August 2023, i2o Therapeutics received a significant boost with a Series A investment. The investors participating in this round remain undisclosed at present. With its focus on pioneering biologic therapies, i2o Therapeutics is poised to make a significant impact in the biotech sector from its headquarters in the United States.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | Unknown | - | 28 Aug 2023 | |
| Venture - Series Unknown | Unknown | - | 11 Oct 2022 | |
| Debt Financing | Unknown | - | 24 Jan 2022 | |
| Debt Financing | Unknown | - | 16 Nov 2020 | |
| Debt Financing | Unknown | - | 23 Mar 2020 |
No recent news or press coverage available for i2o Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
